Drug terminology and pregnancy labeling
Drug classification
Drugs are grouped by classification or class. It is important for a medical assistant to be aware of the class of drugs. Patients will often ask what a specific medication is for, and the medical assistant can provide that information.
Examples of medication classifications
| Classification | Description |
| Analgesic | Relieves pain |
| Anesthetic | Produces local or general anesthesia |
| Antacid | Neutralizes stomach acid |
| Anti-Alzheimer | Treats dementia (Alzheimer disease) |
| Antianxiety | Reduces anxiety and tension |
| Antiarrhythmic | Treats heart arrhythmias |
| Antibiotic | Treats bacterial infections |
| Anticholinergic | Reduces smooth muscle spasms |
| Anticoagulant | Reduces blood clotting ability |
| Anticonvulsant | Reduces the frequency and severity of seizures |
| Antidepressant | Treats depression |
| Antiemetic | Reduces nausea and vomiting |
| Antifungal | Treats fungal infections |
| Antigout | Reduces the uric acid in the body |
| Antihistamine | Relieves allergies by blocking the histamine action |
| Antihyperglycemic | Reduces the blood glucose level |
| Antihypertensive | Lowers blood pressure |
| Anti-inflammatory | Reduces inflammation |
| Antimigraine | Treats or prevents migraine headaches |
| Antineoplastic | Slows or stops the growth of cancer cells |
| Antiplatelet | Prevents the function of platelets (formation of clots) |
| Antipsychotic | Alters the chemical actions in the brain |
| Antitussive | Suppresses coughs |
| Antiviral | Treats viral infections |
| Bronchodilator | Relaxes the smooth muscles of the bronchi |
| Cholesterol-lowering agent | Reduces low-density lipoprotein and triglycerides in the blood while increasing the high-density lipoprotein |
| Contraceptive | Inhibits conception (prevents pregnancy) |
| Corticosteroid | Reduces inflammation |
| Decongestant | Relieves nasal and sinus congestion |
| Diuretic | Increases urinary output and lowers blood pressure |
| Electrolyte | Maintains normal electrolyte level and proper functioning of the body systems |
| Erectile dysfunction agent | Facilitates an erection |
| Expectorant | Thins bronchial secretions, making it easier to cough up the mucus |
| Hematopoietic | Promotes blood cell production |
| Hemostatic | Clots blood |
| Hormone replacement | Replaces hormones or compensates for hormone deficiencies |
| Laxative | Promotes stools |
| Leukotriene receptor antagonist | Blocks the action of substances that cause asthma and allergic rhinitis |
| Muscle relaxant | Relaxes skeletal muscle; reduces muscle spasms and tension |
| Osteoporosis agent | Promotes bone mineral density; used to treat osteoporosis |
| Proton-pump inhibitor | Reduces the acid produced in the stomach |
| Sedative-hypnotic | Slows brain activity, allowing sleep |
| Stimulant | Stimulates the brain and body, makes the person more alert |
Drug terminology
Regardless of how drug reference information is obtained, it is important for the medical assistant to understand the terminology. The following terminology is typically found in drug reference information:
- Names: Usually, the generic name is listed with the trade names. Some references may indicate if the trade name found is in the United States or Canada.
- Description: Describes the medication and its general use.
- Boxed warning: Also referred to as a black box warning. It addresses serious or life-threatening risks. This information also appears on the drug’s label.
- Dosage: Specifies the route, dose, and timing of the medication; usually corresponds to an indication (disease or condition). May provide information on doses for different age ranges. Maximum dosage indicates the greatest amount of medication a person should have within a 24-hour period.
- Indications: Conditions or diseases for which the drug is used.
- Dosage considerations: Indicates recommended changes in dosages for special populations (e.g., patients with hepatic impairment, renal impairment).
- How supplied: Lists the form (e.g., chewable tablets, capsules) and the strength (e.g., 250 mg).
- Administration: Provides information on how the medication should be administered. Includes important administration techniques, such as information on shaking the medication, if it needs to be taken with food, and so on.
- Action: How the drug provides therapeutic results in the body or the use of the drug.
- Adverse reactions: Also called side effects in some information. This section describes known undesirable experiences associated with the medication. Reactions may be divided into severe (life threatening, serious reactions), moderate, and mild.
- Interactions: Includes medications, foods, and beverages that interact with the medication. These products may either increase or reduce the medication level in the blood. They may also increase the risk of adverse reactions if taken together with the drug.
- Contraindications: Reasons or conditions that make administration of the drug improper or undesirable. For example, aspirin is contraindicated in patients with GI bleeding.
- Precautions: Indicates necessary actions or special care that needs to be taken when the patient is on the medication. May include information on laboratory tests, special populations (children and geriatric), pregnancy, breastfeeding, and so on. (More information is discussed in the following section.) In short, a contraindication means the drug should not be given at all in that situation, while a precaution means the drug may still be given but requires added monitoring or caution.
- Pharmacokinetics: Provides information on the absorption, distribution, metabolism, and excretion of the medication. Information on when the drug is at its highest level in the body or when it starts working may be included. The following terms are important for understanding the pharmacokinetics of a drug:
- Biological half-life: The time it takes half of the drug to be metabolized or eliminated by normal biological processes
- Onset: The time it takes for the drug to produce a response
- Peak: The time it takes for the drug to reach its greatest effective concentration in the blood
- Duration: The time during which the drug is present in the blood at great enough levels to produce a response
Pregnancy and lactation labeling rule
Since 1979 the Food and Drug Administration (FDA) has enforced the use of pregnancy risk categories. The A, B, C, D, and X categories indicate the risk to the baby in utero. In 2015 the Pregnancy and Lactation Labeling Rule (PLLR) replaced the pregnancy risk letter categories with more comprehensive information. The goal is to supply the provider and patient with pregnancy and lactation information. This information can be used when discussing the risks versus the benefits of a medication. The FDA created the new system to help with patient-specific counseling and informed decision making for pregnant and breastfeeding mothers who need medication therapies. The system consists of three subcategories with detailed information about the following:
- Pregnancy: Includes information on the risks during pregnancy for the mother and baby, in addition to data on the risk of adverse developmental outcomes
- Lactation: Includes information on the presence of the drug in breast milk, the effects on a breastfed child, and the impact on milk production
- Females and males of reproductive potential: Includes information about when pregnancy testing or contraception is required during drug therapy and data that suggests drug-associated fertility effects